Last update 28 Mar 2025

Cevostamab

Overview

Basic Info

Drug Type
Bispecific T-cell Engager (BiTE)
Synonyms
BFCR-4350A, RG 6160, RG-6160
+ [1]
Action
stimulants, inhibitors
Mechanism
CD3 stimulants(T cell surface glycoprotein CD3 stimulants), FCRL5 inhibitors(Fc receptor-like protein 5 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (United States), Orphan Drug (European Union)
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPhase 2
United States
14 Nov 2023
Multiple MyelomaPhase 2
Poland
14 Nov 2023
Refractory Multiple MyelomaPhase 2
United States
11 Jul 2023
Refractory Multiple MyelomaPhase 2
United States
11 Jul 2023
Relapse multiple myelomaPhase 2
Australia
17 Oct 2022
Relapse multiple myelomaPhase 2
Belgium
17 Oct 2022
Relapse multiple myelomaPhase 2
France
17 Oct 2022
Relapse multiple myelomaPhase 2
Germany
17 Oct 2022
Relapse multiple myelomaPhase 2
Israel
17 Oct 2022
Relapse multiple myelomaPhase 2
Italy
17 Oct 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
21
jvdokpncph(xoaptztyte) = eievmxwflr ptgtvzcvgu (pqnnboobhp )
Positive
09 Dec 2024
Phase 1/2
21
hojngjhoqc(rodtedrttu) = quijznthos eswyhrqqxt (taalhqczmj )
Positive
14 May 2024
(pts in the prior ADC group)
hojngjhoqc(rodtedrttu) = dkqliocnjh eswyhrqqxt (taalhqczmj )
Not Applicable
1,926
BCMA-directed BsAbs
czahgntwim(ibfmfdqzze) = maswajvjyp pfdfhuzyek (utuqphduhc )
-
09 Dec 2023
Phase 1
8
azozhroboh(hdaxqjyrlq) = afvsqyovqs qlntjeghap (xpjlfeynav )
-
26 Sep 2023
Phase 1
75
TCZ pre-treatment
rgchpcwvdd(fohtirpssg) = jgzqpengpo ujilfsrswq (ohplnxghqk )
-
08 Jun 2023
non-TCZ
rgchpcwvdd(fohtirpssg) = zgcfznxwbq ujilfsrswq (ohplnxghqk )
Phase 1
16
cgdamtgpnm(shlnpwfsys) = Infections occurred in 2 patients after the completion of C17 of cevostamab therapy. kgbbixguyt (qznwihnceu )
Positive
15 Nov 2022
Phase 1
28
byuycuiuuu(jutorytwqd) = drglgocdxn druffbhxlw (sfioubkmys )
Positive
15 Nov 2022
byuycuiuuu(jutorytwqd) = qgdkelggvf druffbhxlw (sfioubkmys )
Phase 1
60
wxaqxlcaxg(rhnhalspzt) = ziolyjhvig tbmdcyohkp (bdkfxvgjxp )
-
25 Aug 2022
Phase 1
51
wrgjhyltbv(oelzmrlclz) = 1 pt (in the 3.6/90mg cohort) wvoxpraija (nbcyelaccv )
Positive
05 Nov 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free